The Role of Biostatistics in a Centralised Service Provision (CSP) Approach to Clinical Development
In today’s environment, one of the keys to accelerating drug development decisions comes from ready access to historical data. The introduction of the Centralised Service Provision (CSP) approach enables data across study phases and programmes to be accessed as easily as within the same study, due to the commonality of structure. Karen Ooms at Quanticate looks at howdata leads to evidence-based decisions, and it is the resolution, accurate classification and speed of retrieval of data that makes the difference between taking a risk and making a judgement.
http://jforcs.com/jcs/wp-content/uploads/edd/2012/11/3-The-Role-of-Biostatistics-in-a-Centralised-Service-Provision-CSP-Approach-to-Clinical-Development.pdf